A Nine-Year Diagnostic Odyssey of Refractory Psychiatric Symptoms Resolving After Resection of a CA19-9-Producing Ovarian Teratoma: A Case Report and Literature Review.
[BACKGROUND] Ovarian teratomas are increasingly recognized as triggers for autoimmune processes, including neuropsychiatric syndromes.
- 연구 설계 systematic review
APA
Chen W, Zhuang X, et al. (2026). A Nine-Year Diagnostic Odyssey of Refractory Psychiatric Symptoms Resolving After Resection of a CA19-9-Producing Ovarian Teratoma: A Case Report and Literature Review.. Brain and behavior, 16(4), e71370. https://doi.org/10.1002/brb3.71370
MLA
Chen W, et al.. "A Nine-Year Diagnostic Odyssey of Refractory Psychiatric Symptoms Resolving After Resection of a CA19-9-Producing Ovarian Teratoma: A Case Report and Literature Review.." Brain and behavior, vol. 16, no. 4, 2026, pp. e71370.
PMID
41917767
Abstract
[BACKGROUND] Ovarian teratomas are increasingly recognized as triggers for autoimmune processes, including neuropsychiatric syndromes. This report describes a rare case of isolated autoimmune psychosis associated with an ovarian teratoma and reviews the relevant literature.
[CASE PRESENTATION] A 15-year-old female with a 9-year psychiatric history was initially diagnosed with schizophrenia. Her symptoms, refractory to multiple antipsychotic regimens, included emotional instability, impulsive aggression, and perceptual abnormalities. Abdominal ultrasonography revealed a giant ovarian teratoma with significantly elevated CA19-9. Histopathology confirmed neural tissue. Following tumor resection, her psychiatric symptoms resolved dramatically, enabling a return to normal schooling.
[LITERATURE REVIEW] Our systematic review identified 32 cases of teratoma-associated psychosis. Notably, only 2 cases (7.7%) presented without encephalitic features, with one being seronegative for NMDA antibodies. This highlights the exceptional nature of our "pure" psychiatric presentation.
[CONCLUSIONS] Ovarian teratomas may be associated with suspected cases of isolated autoimmune psychosis, even in the absence of typical neurological signs or positive autoantibodies. In such instances, CA19-9 elevation could serve as a nonspecific clue. Comprehensive imaging remains crucial for patients with atypical, treatment-resistant psychosis to avoid diagnostic delays.
[CASE PRESENTATION] A 15-year-old female with a 9-year psychiatric history was initially diagnosed with schizophrenia. Her symptoms, refractory to multiple antipsychotic regimens, included emotional instability, impulsive aggression, and perceptual abnormalities. Abdominal ultrasonography revealed a giant ovarian teratoma with significantly elevated CA19-9. Histopathology confirmed neural tissue. Following tumor resection, her psychiatric symptoms resolved dramatically, enabling a return to normal schooling.
[LITERATURE REVIEW] Our systematic review identified 32 cases of teratoma-associated psychosis. Notably, only 2 cases (7.7%) presented without encephalitic features, with one being seronegative for NMDA antibodies. This highlights the exceptional nature of our "pure" psychiatric presentation.
[CONCLUSIONS] Ovarian teratomas may be associated with suspected cases of isolated autoimmune psychosis, even in the absence of typical neurological signs or positive autoantibodies. In such instances, CA19-9 elevation could serve as a nonspecific clue. Comprehensive imaging remains crucial for patients with atypical, treatment-resistant psychosis to avoid diagnostic delays.
MeSH Terms
Humans; Female; Teratoma; Ovarian Neoplasms; Adolescent; CA-19-9 Antigen; Psychotic Disorders
같은 제1저자의 인용 많은 논문 (5)
- FcγRIIb deficiency inhibits tumor development by attenuating the immunosuppressive phenotype of MDSCs.
- Effectiveness of KAP-based nursing program in managing digestive symptoms in colorectal cancer patients undergoing chemotherapy: A retrospective controlled study.
- Oligometastatic Prostate and Bladder Cancer: An Integrative Narrative Review.
- Real world deployment of a pancreatic cancer risk model: impact of refitting, imputation, and computational burden.
- IRF1 suppresses gastric tumorigenesis via dual PI3K/AKT-ERK pathway modulation and functional antagonism of oncogenic MX2.